Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
Edina Wang(The University of Western Australia), Pilar Blancafort(The University of Texas at San Antonio Health Science Center)
Cited by 81
Related Papers
Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
|Nucleic Acids Research|2012|169
Generation of tumor-initiating cells by exogenous delivery of OCT4transcription factor
|Breast Cancer Research|2011|94
Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system
|Oncotarget|2016|88
Suppression of Breast Tumor Growth and Metastasis by an Engineered Transcription Factor
|PLoS ONE|2011|55
Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers
|Chemical Science|2019|55